Nature Outlook |

Huntington’s disease

There is fresh hope for treating Huntington’s disease, an inherited neurodegenerative condition that causes uncontrollable movements, emotional disturbance and the loss of mental abilities. But biological mysteries remain.

This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.

This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.

Despite gaps in our understanding of the biology that underlies this neurodegenerative condition, potential treatments are on the horizon.

Outlook | | Nature

Roche in partnership with Ionis Pharmaceuticals is committed to supporting the needs of the community living with Huntington’s disease (HD) and developing treatments for those affected by this devastating disease. We invited journalist and HD patient advocate Charles Sabine to give his perspective at an event organized at Roche in recognition of World Rare Disease Day 2018.

Sponsor Feature |

Although potential treatments are now entering the pipeline, the molecular cause and progression of Huntington’s disease continue to elude researchers.

Outlook | | Nature